[Beta blockers in antihypertensive treatment].
Beta blockers are drugs of first choice for the treatment of essential hypertension today and may be combined with other antihypertensive drugs or diuretics. Use of highly selective beta-1 receptor-blocking agents without intrinsic sympathomimetic activity is particularly recommended for hypertensive patients after transmural myocardial infarction who suffer from exercise-dependent myocardial ischemia. Highly selective beta-1 receptor-blocking agents have only little influence on the lipid metabolism; however, if prescribed in diabetic patients treated with insulin, in patients with cardiac failure or in asthmatic patients, close supervision is mandatory.
Evéquoz
D
D
Departement Medizin, Universitätsklinik, Bern.
Erne
P
P
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D001786:Blood Glucose; D016084:Bronchoconstriction / Q000187:drug effects; D006332:Cardiomegaly / Q000188:drug therapy; D000075202:Contraindications; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D050356:Lipid Metabolism; D011788:Quality of Life; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D018342:Receptors, Adrenergic, beta-1
Betablocker in der antihypertensiven Behandlung.